1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Avonex PS-Drug Insights, 2015

Avonex PS-Drug Insights, 2015

  • April 2015
  • -
  • Delve Insight

SUMMARY
DelveInsight’s pharmaceuticals report, “Avonex PS- Drug Insights, 2015” highlights the Avonex PS marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the “Avonex PS covering the total sales estimation for the countries in which the drug is approved and also provides the Avonex PSsales performance during the forecast period (2012-2016). DelveInsight’s Report has also covered the detailed clinical assessment of the “Avonex PS, detailed patents information and market exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report is also providing the SWOT analysis for the Avonex PS.


Data Sources

DelveInsight’s pharmaceuticals report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.


Scope

- A review of the Avonex PS based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Avonex PS on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Avonex PS with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2012-2016
- Qualitative and quantitative assessment of market space
- SWOT Analysis


Reasons to buy


- Evaluate the marketing status and exclusivity details of Avonex PS to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Avonex PS.
- API intelligence over Avonex PS and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis ofAvonex PS.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2012-2016

Table Of Contents

Avonex PS-Drug Insights, 2015
Table of Contents

- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for theEurope
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables

- Avonex PS, Market, Global Sales (in USD), 2015
- Avonex PS, Description
- Avonex PS, Marketed Details the United States (US)
- Avonex PS, Marketed Details the Europe (EU)
- Avonex PS, Patent/Exclusivity Expiry (Year), 2015
- Avonex PS, Patent Number Specific Patent Expiry (Year), 2015
- Avonex PS, Patent Details
- Avonex PS, Route of Synthesis
- Avonex PS, the United States Drug Master File (US DMF), 2015
- Avonex PS, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2015
- Avonex PS, the API Manufacturers, China, 2015
- Avonex PS, the API Manufacturers, India, 2015
- Avonex PS, the API Manufacturers by the US DMF Status, 2015
- Avonex PS, the API Manufacturers by Region, 2015
- Avonex PS, the API Manufacturers by Location/Countries, 2015
- Avonex PS, Generic Players, 2015
- Avonex PS, Pipeline Drug Details, 2015
- Avonex PS, Clinical Trials, 2015
- Avonex PS, Clinical Trials by Zone, 2015
- Company Overview, 2015
- Avonex PS, SWOT Analysis, 2015
- Phase III Pipeline Therapeutics, 2015


List of Figures

- Avonex PS,Market, Global Sales (in million USD), 2015
- Avonex PS, Global Sales % Change, 2015
- Avonex PS, Patent/Exclusivity Expiry (Year), 2015
- Avonex PS, Patent Number Specific Patent Expiry (Year), 2015
- Avonex PS, Route of synthesis
- Avonex PS, the API Manufacturers by the US DMF Status (%), 2015
- Avonex PS, the API Manufacturers by Region, 2015
- Avonex PS, the API Manufacturers by Location/Countries, 2015
- Avonex PS, Generic Players, 2015
- Avonex PS, Clinical Trials by Zone (%), 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.